Life Sciences Future  October 29-30, 2018, Pennsylvania Convention Center, Philadelphia, PA

The Company Presentation Stage of Life Sciences Future provides an unparalleled opportunity for small and emerging companies to present their technology, data, business plan, and opportunities for investment and partnership to a large and diverse life sciences audience.  Selected companies will have ten minutes to present to an audience that includes global pharma and device companies, investor groups, research institutions, fellow startups, key strategic partners, and others.

The best Company Presentation candidates have demonstrated some ability to raise funds (e.g. completed a seed round or more) and have relevant data to present. They are in a position to make a specific pitch for investment or partnership and explain how it will advance their company. Alternatively, candidates could be more mature companies developing a new product or showcasing new partnering opportunities. Qualifying presenters must be from Core companies (i.e. biotech, pharmaceutical, medical device, diagnostic, or digital health). Service Providers are not eligible to present. 

If you have any questions regarding the Life Sciences Future conference or the Company Presentation stage, please contact Karen DeLone, Life Sciences Pennsylvania. 610-947-6800, ext. 210. kdelone@lifesciencespa.org 

Thank you for your interest in Life Sciences Future.

Company Information:

Question Title

* 1. Company Information:

Mailing Address:

Question Title

* 2. Mailing Address:

Other Information:

Question Title

* 3. Other Information:


Presentation Objectives: (150 Word Limit)

Question Title

* 4. Presentation Objectives: (150 Word Limit)

Please select up to three of the categories listed below on which your company will focus:

Question Title

* 5. Please select up to three of the categories listed below on which your company will focus:

Owners: (Public, Private, Other)

Question Title

* 6. Owners: (Public, Private, Other)

Company Background:
Therapeutic Area(s):

Question Title

* 7. Company Background:
Therapeutic Area(s):

Technology & Current Research: (300 Word Limit)

Question Title

* 8. Technology & Current Research: (300 Word Limit)

Partnership Strategy and/or Current Alliances: (300 Word Limit)

Question Title

* 9. Partnership Strategy and/or Current Alliances: (300 Word Limit)

Recent Milestones: (300 Word Limit)

Question Title

* 10. Recent Milestones: (300 Word Limit)

Anticipated Milestones: (150 Word Limit)

Question Title

* 11. Anticipated Milestones: (150 Word Limit)

Expected Launch of First Product/Launch Product Sales to Date:

Question Title

* 12. Expected Launch of First Product/Launch Product Sales to Date:

Company Management: Chief Executive Officer/Top Company Official

Question Title

* 13. Company Management: Chief Executive Officer/Top Company Official


Other Senior Officers:

Question Title

* 14. Other Senior Officers:

Additional Information: (150 Word Limit)

Question Title

* 15. Additional Information: (150 Word Limit)


Companies selected to present will have their presentation deck (non-confidential) reviewed by the Company Presentation Committee in advance of the conference. The committee is composed of experienced life sciences professionals across a variety of subject matter areas--biotech, devices, legal, marketing, etc.--who have experience with the LSF Company Presentation format. They will provide custom feedback to help companies hone their presentation for the LSF audience. 

Question Title

* 16. Companies selected to present will have their presentation deck (non-confidential) reviewed by the Company Presentation Committee in advance of the conference. The committee is composed of experienced life sciences professionals across a variety of subject matter areas--biotech, devices, legal, marketing, etc.--who have experience with the LSF Company Presentation format. They will provide custom feedback to help companies hone their presentation for the LSF audience. 



T